Got questions about the FDA’s new plans around pharmaceutical ads? We’ve got answers.

Amid deadly shootings, CDC has fired experts and shut down research on preventing gun violence. Expert calls it a "cruel irony."

FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications

A much-investigated question about autism, dismissed in many studies, is getting a surge of new federal research money.

This week on "The Readout LOUD": A drug-industry career reshaped by illness, and the potential for political blowback against Chinese biotech.

Three scientists who revolutionized the treatment of cystic fibrosis and prolonged the lifespan of patients with the deadly disease have won the Lasker Award.

A new liquid biopsy test from Exact Sciences scans for 50 cancers in one blood sample. The company says it marks a new era in early detection, but there are…

The FDA is aiming to reduce reliance on opioids by providing guidance on the development of prescription non-opioid treatments for chronic pain.

The FDA will convene experts on Nov. 6 to discuss challenges around regulating mental health products that use artificial intelligence.

In today's Morning Rounds newsletter, the latest data on chronic disease deaths, new pharma interest in psychedelics, and more.